| Literature DB >> 35884025 |
Sarah A Sobotka1, Emma J Lynch1, Ayesha V Dholakia2, Anoop Mayampurath3, Neethi P Pinto4.
Abstract
Our understanding of longitudinal outcomes of Pediatric Intensive Care Unit (PICU) survivors is limited by the heterogeneity of follow-up intervals, populations, and outcomes assessed. We sought to demonstrate (1) the feasibility of longitudinal multidimensional outcome assessment and (2) methods to promote cohort retention. The objective of this presented study was to provide details of follow-up methodology in a PICU survivor cohort and not to present the outcomes at long-term follow-up for this cohort. We enrolled 152 children aged 0 to 17 years admitted to the PICU in a prospective longitudinal cohort study. We examined resource utilization, family impact of critical illness, and neurodevelopment using the PICU Outcomes Portfolio (POP) Survey which included a study-specific survey and validated tools: 1. Functional Status Scale, 2. Pediatric Evaluation of Disability Inventory Computer Adaptive Test, 3. Pediatric Quality of Life Inventory, 4. Strengths and Difficulties Questionnaire, and 5. Vanderbilt Assessment Scales for Attention Deficit-Hyperactivity Disorder. POP Survey completion rates were 89%, 78%, and 84% at 1, 3, and 6 months. Follow-up rates at 1, 2, and 3 years were 80%, 55%, and 43%. Implementing a longitudinal multidimensional outcome portfolio for PICU survivors is feasible within an urban, tertiary-care, academic hospital. Our attrition after one year demonstrates the long-term follow-up challenges in this population. Our findings inform ongoing efforts to implement core outcome sets after pediatric critical illness.Entities:
Keywords: PICU follow-up; PICU survivors; feasibility; long-term outcomes; neurodevelopment
Year: 2022 PMID: 35884025 PMCID: PMC9317147 DOI: 10.3390/children9071041
Source DB: PubMed Journal: Children (Basel) ISSN: 2227-9067
Figure 1Study enrollment.
Demographic and clinical characteristics of study cohort.
| Characteristic | Enrollment/Discharge (n = 152) |
|---|---|
| Age in years, mean (SD) | 5.2 (5.2) |
| Sex, n (%) | |
| Male | 89 (58.6) |
| Female | 63 (41.4) |
| Race, n (%) | |
| Black | 87 (57.2) |
| White | 51 (33.6) |
| Other | 14 (9.2) |
| Ethnicity, n (%) | |
| Hispanic | 14 (9.2) |
| Non-Hispanic | 138 (90.8) |
| Primary Diagnosis, n (%) | |
| Pulmonary | 60 (39.5) |
| Surgical | 33 (21.7) |
| Neurologic | 13 (8.6) |
| Trauma | 12 (7.9) |
| Infection | 11 (7.2) |
| Other | 23 (15.1) |
| Admission PSOFA, mean (SD) ° | 4.6 (2.4) |
| Admission PRISM, mean (SD) ° | 9.2 (4.5) |
| Median length of PICU stay °, days (IQR) | 3.0 (1.7–8.1) |
| Median length of Hospital stay °, days (IQR) | 4 (3–9) |
° admission pSOFA and PRISM calculated as maximum scores within 24 h of PICU admission, hospital LOS calculated as full days during hospitalization encounter; PICU stay determined by time of first and last vital-sign recordings.
Figure 2Cohort retention and follow-up among PICU survivors. * POP survey = impact survey, functional status scale (FSS), Pediatric Evaluation of Disability Inventory Computer Adaptive Test (PEDI-CAT), Pediatric Quality of Life InventoryTM (PedsQL), Strengths and Difficulties Questionnaire (SDQ), and Vanderbilt Assessment Scales for Attention Deficit-Hyperactivity Disorder (Vanderbilt); PEDI-CAT was not included at 1- and 2-year follow-up.
Characteristics of successful follow-up attempts.
| Follow-Up Interval | ||||||
|---|---|---|---|---|---|---|
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
| Number of follow-up attempts, median (IQR) | 2 (1–4) | 2 (1–3) | 2 (1–3) | 3 (2–6) | 2 (1–4) | 4 (3–5) |
| Day | ||||||
| Weekday completion, n (%) | 127 (96.2) | 112 (97.4) | 115 (93.5) | 104 (88.9) | 69 (87.3) | 48 (85.7) |
| Weekend completion, n (%) | 5 (3.8) | 3 (2.6) | 8 (6.5) | 13 (11.1) | 10 (12.7) | 8 (14.3) |
| Time * | ||||||
| Daytime completion, n (%) | 116 (89.2) | 99 (91.7) | 94 (82.4) | 88 (76.5) | 57 (72.2) | 38 (67.9) |
| Evening completion, n (%) | 14 (10.8) | 9 (8.3) | 20 (17.35) | 27 (23.5) | 22 (27.8) | 18 (32.1) |
| Days to completion after follow-up eligible, median (IQR) | 9 (0–34.3) | 26 (10.5–68) | 23 (6.5–49) | 28 (9–65) | 12 (2–28) | 38.5 (17.3–124.8) |
| Completed at later follow-up interval, n (%) | 19 (14.5) | 21 (19.3) | 1 (0.8) | N/A | N/A | N/A |
* Time follow-up was not captured for a minority of patients (<10% at all intervals).